cerrar
Tagged with Europe

Tending the Garden of RWD via Project EHDEN: 21st Century Tools…
Nigel Hughes of the European Health Data & Evidence Network (EHDEN) outlines EHDEN's scope and purpose and highlights why greater collaboration on…

A New Industrial Strategy for Europe: Win-Win for Both Economies…
The EFPIA's Nathalie Moll outlines the case for a new EU-wide industrial strategy with biopharmaceuticals at its heart. The…

Countering Hospital-Acquired Infections with a Culture of Safety
Becton Dickinson's Fiona Garín looks at the rise of Healthcare-Acquired Infections (HAIs) in Europe and how an industry-wide culture of safety needs…

Christina M. Busmalis of IBM Watson Health
IBM Watson Health’s Director for Global Life Sciences & Go-To Market Leader for Europe & Asia Pacific Christina Busmalis gives her insights…

Hungary’s National Champions Betting on Biosimilars
Hungary’s two largest pharma firms, Egis Pharmaceuticals and Gedeon Richter, are stepping up their biosimilars offering; providing the European…

Drug Shortages Hitting Hungary Hard
Like many of its European counterparts, Hungary is suffering from medicine shortages. Vaccines, vitamins, and orphan drugs are some of the most…

Data for Safer Care: AI in Healthcare-Associated Infections
Awareness is growing of the dangers of healthcare-associated infections (HAIs) in Europe, and conversations are beginning to taking place around how…

Hungary: Falling Behind for Innovative Medicines
Hungarian patients currently experience longer wait times and more limited access to subsidised innovative medicines than their neighbours in Bulgaria…

Central & Eastern Europe Pharma Market Snapshot
Poland is by far the largest pharma market in the Central and Eastern Europe (CEE) region, with a total value of EUR 6.352 billion for 2017. The Czech…

Christoph Stoller of Medicines for Europe on Tackling Drug…
Christoph Stoller, general manager for Austria and Germany at Teva was recently elected president of Medicines for Europe, the continent-wide…

Oncology Care in Hungary: In Need of Reform
Cancer is on the rise in Hungary and survival rates are considerably lower than the European average. The country's innovative pharma association has…

Christoph Stoller – President & Adrian van den Hoven…
Christoph Stoller, the recently appointed president of Medicines for Europe, outlines the mission of his presidency, how the association and its…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here